Capricor Therapeutics Stock Price

-0.02 (-0.41%)
Upgrade to Real-Time
Regular Market


52 Week Range


Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Capricor Therapeutics Inc CAPR NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.02 -0.41% 4.84 13:38:01
Open Price Low Price High Price Close Price Prev Close
4.80 4.69 5.20 4.86
Bid Price Ask Price Spread News
4.84 4.86 0.02 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,081 289,874 $ 4.90 $ 1,421,415 - 3.13 - 12.32
Last Trade Time Type Quantity Stock Price Currency
13:38:13 1 $ 4.85 USD


Draw Mode:

Capricor Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 110.73M 22.88M 22.36M $ 310.25k $ - -0.93 -5.70
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - 14.90%

more financials information »

Capricor Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CAPR Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week4.305.204.21574.89230,5050.5412.56%
1 Month5.605.734.21574.92222,059-0.76-13.57%
3 Months4.716.2243.134.70423,1680.132.76%
6 Months7.60748.403.135.40551,567-2.77-36.38%
1 Year8.2012.323.136.321,049,601-3.36-40.98%
3 Years1.2512.320.25265.951,094,3243.59287.2%
5 Years3.7912.320.25264.89898,0091.0527.7%

Capricor Therapeutics Description

Capricor Therapeutics Inc is a United States-based biotechnology company focused on the discovery, development, and commercialization of first-in-class biological therapies for the treatment of diseases, with a focus on Duchenne muscular dystrophy and other medical conditions. The company's development stage product pipeline includes CAP-1002, for Duchenne Muscular Dystrophy Program and COVID-19 Program; CDC-Exosomes (CAP-2003); and Exosome-mRNA vaccine.

Your Recent History
Capricor T..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.